head and neck cancer market
Dec 23, 2022
Awaited Approval for New Therapies for Head and Neck Cancer Treatment – A Race Against Time!
Head and neck cancer is a complex indication and is common among men and people over 50 and accounts for 3–5% of all cancers in the US. As per the assessment done by DelveInsight, there were approximately 158K incident cases of head and neck cancer in the 7MM in 2021. Among the EU5 countries, Germany had the highes...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
